A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Neurology. 2012 Mar 13;78(11):841. doi: 10.1212/01.wnl.0000413180.13413.ce.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 25-Hydroxyvitamin D 2 / therapeutic use*
  • Female
  • Humans
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Vitamins / therapeutic use*

Substances

  • Vitamins
  • 25-Hydroxyvitamin D 2